RTW Venture Fund Limited Announcement of Share Issuance (2647D)
17 Febbraio 2020 - 6:10PM
UK Regulatory
TIDMRTW
RNS Number : 2647D
RTW Venture Fund Limited
17 February 2020
LEI: 549300Q7EXQQH6KF7Z84
17 February 2020
RTW Venture Fund Limited
(the "Company")
Announcement of Share Issuance
Further to publication of the Company's 31 January 2020 net
asset value, released on 14 February 2020, the Company confirms
that it may issue new ordinary shares at a price of US$1.32 per new
ordinary share, reflecting an 8.2 per cent. premium to the 31
January 2020 net asset value.
The Company intends to issue new ordinary shares on this basis
until 28 February 2020. Investors wishing to participate in this
issuance should reflect their interest to J.P. Morgan Cazenove.
For Further Enquiries
RTW Investments, LP +1 (646) 343 9280
Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Business Development Associate
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
Oliver Kenyon
James Bouverat (Sales)
Estera (Company Secretary) +44 (0)1481 742 642
Kevin Smith
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund
focused on identifying transformative assets with high growth
potential across the biopharmaceutical and medical technology
sectors. Driven by a long-term approach to support innovative
businesses, RTW Venture Fund invests in companies developing
next-generation therapies and technologies that can significantly
improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a
leading US healthcare investment firm with deep scientific
expertise and a strong track record of supporting companies
developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOEUBRBRROUUAAR
(END) Dow Jones Newswires
February 17, 2020 12:10 ET (17:10 GMT)
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Apr 2023 a Apr 2024